Search research articles
Contact Us
Filters
Showing results (71-80 of 103) with videos related to
Page
of 11
Sort By:
JAMA Oncology
|
April 27, 2023
Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab
Adrienne G Waks, Esther R Ogayo, Laia Paré, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2025
Molecular and clinical analyses of gene fusions identify therapeutic targets in paired primary and metastatic breast cancer from the AURORA program (BIG 14-01)
Chiara Biagioni, Danai Fimereli, Alexandre Irrthum, et al.
Clinical Immunology (Orlando, Fla.)
|
January 22, 2025
The immune response to SARS-CoV-2 in COVID-19 as a recall response susceptible to immune imprinting: A prospective cohort study
Daniel Alvarez-Sierra, Mónica Martínez-Gallo, Adrián Sánchez-Montalvá, et al.
International Journal of Molecular Sciences
|
January 8, 2023
A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy
Elena Élez, Núria Mulet-Margalef, Miriam Sanso, et al.
JCO Precision Oncology
|
September 14, 2020
Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials
Rodrigo Dienstmann, Elena Garralda, Susana Aguilar, et al.
Human Mutation
|
December 8, 2017
An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practice
Gillian Ellison, Miika Ahdesmäki, Sally Luke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 22, 2018
Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy
Cristina Cruz, Alba Llop-Guevara, Judy E Garber, et al.
Journal of the National Cancer Institute
|
December 28, 2022
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1
Fara Brasó-Maristany, Gaia Griguolo, Nuria Chic, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 14, 2022
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer
Laura Devis-Jauregui, August Vidal, Laura Plata-Peña, et al.
The Journal of Clinical Investigation
|
June 27, 2018
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
Isabel Puig, Stephan P Tenbaum, Irene Chicote, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 103) with videos related to
Sort By:
Page
of 11
JAMA Oncology
|
April 27, 2023
Assessment of the HER2DX Assay in Patients With ERBB2-Positive Breast Cancer Treated With Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab
Adrienne G Waks, Esther R Ogayo, Laia Paré, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 22, 2025
Molecular and clinical analyses of gene fusions identify therapeutic targets in paired primary and metastatic breast cancer from the AURORA program (BIG 14-01)
Chiara Biagioni, Danai Fimereli, Alexandre Irrthum, et al.
Clinical Immunology (Orlando, Fla.)
|
January 22, 2025
The immune response to SARS-CoV-2 in COVID-19 as a recall response susceptible to immune imprinting: A prospective cohort study
Daniel Alvarez-Sierra, Mónica Martínez-Gallo, Adrián Sánchez-Montalvá, et al.
International Journal of Molecular Sciences
|
January 8, 2023
A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy
Elena Élez, Núria Mulet-Margalef, Miriam Sanso, et al.
JCO Precision Oncology
|
September 14, 2020
Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials
Rodrigo Dienstmann, Elena Garralda, Susana Aguilar, et al.
Human Mutation
|
December 8, 2017
An evaluation of the challenges to developing tumor BRCA1 and BRCA2 testing methodologies for clinical practice
Gillian Ellison, Miika Ahdesmäki, Sally Luke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 22, 2018
Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy
Cristina Cruz, Alba Llop-Guevara, Judy E Garber, et al.
Journal of the National Cancer Institute
|
December 28, 2022
HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1
Fara Brasó-Maristany, Gaia Griguolo, Nuria Chic, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
November 14, 2022
Generation and Integrated Analysis of Advanced Patient-Derived Orthoxenograft Models (PDOX) for the Rational Assessment of Targeted Therapies in Endometrial Cancer
Laura Devis-Jauregui, August Vidal, Laura Plata-Peña, et al.
The Journal of Clinical Investigation
|
June 27, 2018
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
Isabel Puig, Stephan P Tenbaum, Irene Chicote, et al.
Page
of 11